Doctors across India who encounter patients with tuberculosis will have to disclose the identity, age, sex, and address of each patient to local health authorities under an order issued this week by the Union health ministry. The health ministry said today that it is essential to have complete information as part of its efforts to ensure that patients receive proper diagnosis and therapy and to curb the emergence and spread of...
More »SEARCH RESULT
Did Narendra Modi govt pay for SIT chief Raghavan's foreign trips?-Ajay Umat
AHMEDABAD: What was the need for amicus curiae Raju Ramachandran to put down these words in his final report before the Supreme Court which became public this week? "The cost for boarding and lodging for both the amicus curiae at BSF mess, Gandhinagar as well as the cost for local transportation by private taxi was arranged by the SIT...the cost of travel from Delhi to Ahmedabad and back (for both...
More »For a universal old-age pension plan-Prabhat Patnaik
With the elderly likely to constitute a quarter of India's population by 2050, there is need for a publicly-funded, universal scheme that will overcome destitution among the aged India's social security system is woefully inadequate, when compared even to those in third world economies with no higher per capita incomes. Some States in India have fairly comprehensive social security schemes — notably Kerala, also West Bengal and Tamil Nadu — but...
More »Court directs police to register case against godman Nirmal Baba-Ashish Tripathi
A local court on Wednesday directed Luknow police to register a case of fraud and cheating against Delhi based self proclaimed godman Nirmal Baba alias Nirmaljeet Singh Nerula. Chief Judicial Magistrate Rajesh Upadhyaya further directed Gomitnagar police to probe the matter and submit the report in the court. The Judge cited a 1999 Supreme Court ruling and said that if a person present himself as godman capable of treating the disease...
More »Panel exposes flaws in India’s drug approval procedure-Vidya Krishnan
A report by a parliamentary committee has shown that the drug industry regulator, the Drug Controller General of India (DCGI), has been approving, on average, one new drug a month without conducting mandatory clinical trials or seeking expert medical opinion—findings that expose the deep flaws prevalent in India’s drug approval process. The committee has asked the health ministry to withdraw the discretionary powers given to the Central Drugs Standard Control Organization...
More »